MedKoo Biosciences

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

 

 

 


 

Back to products

 

 Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

 


Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

MedKoo product information:

 

 RG7167

  

Description of RG7167: RG7167 is a potent, orally bioavailable, highly selective MEK inhibitor. It potently inhibits the MAPK signaling pathway activation and tumor cell growth. Single-agent oral administration resulted in complete tumor regression in xenograft models.

  

Current developer:    Roche/Genentech; Chugai Pharmaceuticals Co. Ltd.

  

MedKoo Code#:  205609

Name:  RG7167

CAS#:  

 

Synonym:   RG7167; RG 7167; RG-7167; CIF

 

IUPAC/Chemical name: 

 

 

Chemical structure

Theoretical analysis

 

 

 

 

 

 

 

Availability and price:

This agent is not in stock,  may be  available through  custom synthesis.

 

To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

 

 

Information about this agent

    

  

 

References

 

 

 

Contact MedKoo:

Email: sales@medkoo.com

 

(Keyword; CAS#; MedKoo code#)

 

 

 

 

 

 

 

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

© MedKoo Biosciences. All Rights Reserved